Tuesday, June 18, 2019

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $OGI.V) (NASDAQ: $OGI) (TSXV: $META.V)( CSE: $CRFT.C) (CSE: $TIM_U.C)

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (TSXV: $OGI.V) (NASDAQ: $OGI) (TSXV: $META.V)( CSE: $CRFT.C) (CSE: $TIM_U.C)



Delta, Kelowna, BC –June 18, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:



Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today we are looking at a few early announcements.

But first, The Global Cannabis Partnership (GCP), a collaboration of leaders in the government-sanctioned cannabis industry, released today a corporate social responsibility framework that its 45-member organizations have agreed to adhere to, establishing a standard for the new and rapidly growing cannabis industry worldwide.
         
"We're building an industry for the future," said the GCP's Executive Director Kim Wilson. "It's one thing to have a legal license to operate; earning and keeping a social license is another story. We have a long road ahead of us, but today's announcement is an important step in the right direction."       
The world's first Responsible Cannabis Framework (RCF) seeks to positively influence the industry's impacts on the environment and society, and aims to support GCP members in continually improving their corporate performance over time.
Using best practices from within and outside the industry, the RCF goes beyond minimum compliance with all relevant and applicable laws, articulating expectations of members for evaluating, developing, implementing, measuring and disclosing their environmental, social and governance initiatives.
"The RCF was developed through extensive research and consultation with a variety of stakeholders," said Rick Petersen, one of the world's experts in corporate responsibility and author of the Framework. "We knew that we could rely on the experience of other industries, while at the same time coming up with the right steps to meet the challenges in our specific sector."
Members have all agreed to the Framework's four guiding principles – responsibility, collaboration, transparency and continuous improvement – and have up to a year to complete work necessary to apply for one of four certification categories. Minimum requirements include, among others, minimizing greenhouse gas emissions; promoting responsible use, and reinforcing ethical conduct. The formal certification process was developed by EY and member applications will be submitted to an independent evaluation panel.
The GCP expects members to make improvements when Framework standards are not met and to develop mechanisms to ensure ongoing compliance and continuous improvement.

Organigram Holdings Inc. (TSXV: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, announced that it has signed an exclusive agreement with Feather Company Ltd., a cannabis innovator and lifestyle brand committed to the production of premium-quality products that enhance the cannabis experience for customers. The disposable vaporizer pen and 5/10 thread cartridges for targeted adult-use customer segments will be available following legalization of this product category currently scheduled to come into effect as of October 2019.

Organigram, through the Edison Cannabis Co. brand, has an exclusive license to Feather's proprietary vaporizer pen technology and form factor. The relationship will also allow Organigram to represent Feather across Canada from a commercial perspective. This agreement reflects both companies' commitment to transformative thinking a­­nd unique customer experiences.
"A successful recreational cannabis market requires that licensed producers and their partners continually reimagine the cannabis experience," says Ray Gracewood, Senior Vice President, Marketing and Communications, Organigram. "It is critical for Organigram to find unique ways to offer customers the kind of value that will help differentiate our brands. The future is in providing unique opportunities for customers to explore the product."

Feather's technology and hardware offers Organigram's Edison brand a unique, proprietary delivery mechanism for discerning and sophisticated consumers and will compliment the companies recently announced partnership with PAX, a leader in closed-loop vaporizable technology offered through the PAX Era product line.

National Access Cannabis Corp. (TSXV: META), Canada's largest cannabis retailer according to provincial licensing statistics, today announced it has received three additional licences from the Alberta Gaming, Liquor and Cannabis Commission to open cannabis retail stores in Alberta. The retail stores will be located in the cities of Calgary, Edmonton and Airdrie. The announcement comes following the previously released news that the AGLC has lifted the moratorium on new cannabis retail licences.

"We're growing rapidly in Alberta," said Mark Goliger, CEO of NAC. "With three new licences and the new location recently opened June 5th in the Varsity neighbourhood in Calgary, we continue to expand our private cannabis retailing footprint in Alberta and our growth isn't done. We have 15 additional licences submitted and 7 more stores built awaiting licensing and regulatory approval in Alberta."

NAC is the national leader in retail cannabis. Currently operating in three provinces, NAC has applied for licences in British Columbia and plans to make applications for licences in Ontario once licensing opens up to more private retailers. NAC's experienced team of retail industry professionals is focused on achieving its business plan of having 40 operating stores by the end of calendar 2019, and 110 operating stores by the end of calendar 2020.

Pasha Brands Ltd. (CSE: CRFT) (OTC:CRFTF) introduced BC Craft Supply Co. Ltd. as the first in its line of nearly a dozen leading craft cannabis brands that aim to rectify Canada's ongoing product shortage and quality issues. Through its subsidiaries, Pasha is Canada's first licensed producer exclusively focused on assisting the original cannabis industry in Canada in gaining access to the regulated market through Health Canada's new micro cultivation licensing regime.

BC Craft is helping Canada's leading cannabis growers acquire micro-cultivation licences by providing comprehensive support and advice, as well as all necessary testing, processing and packaging to help growers legally bring their products to market. With Pasha's recent acquisition of Medcann Health Products Ltd., a fully licensed, Health Canada approved facility, BC Craft is uniquely positioned to work with the thousands of craft producers in Canada that are now looking to transition into Canada's new regulated supply chain.

"I'm confident that what BC Craft Supply Co. will be able to contribute to the legal market will set the standard for craft production and supply chain management, not just in Canada but internationally," said Jason Longden, CEO of Pasha Brands. "Confidence in the brand has already inspired craft cultivators throughout British Columbia and from across the country to join our team, and we're eager to help solve Canada's ongoing supply issue with quality cannabis the legal market has yet to see."

Representing the first wave of Pasha's industry-shaking craft cannabis brands, BC Craft is a service provider in contract with some of Canada's best farmers to ensure their timely participation and competitive edge in Canada's burgeoning legal cannabis market. Spurred by a passion to support small businesses and pay respect to the cultivators that have always been the country's top choice for quality cannabis, the brand is working to assist in their transition into the market so that consumers can have legal access to legitimate and sought-after 'BC Bud' at long last.

With Medcann now part of the Pasha group, BC Craft will coordinate the purchase of craft cannabis from licensed micro cultivators under a supply agreement, kicking off the transition from the unregulated market—where nearly 85 percent of all cannabis sales in Canada still take place—to the legal one. Once micro cultivators are licensed and operational, BC Craft anticipates an annual supply of approximately 50,000 kilograms of cannabis per 100 micro cultivators in its supply chain. Industry estimates place the number of grey market producers in BC alone at as many as 20,000.

Jose Hidalgo, Founder and CEO of Cansortium Inc. (CSE: TIUM-U), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent™ brand, issued the following statement in response to Texas Governor Greg Abbott's signing of HB 3703 which expands access to low-level THC (less than 0.5%) cannabis products to benefit Texas residents coping with certain chronic medical conditions.
"The Cansortium team is excited to work with the State of Texas to provide cultivation, processing and home delivery operations in Texas in order to bring the benefits of our premium-grade, low-level THC, cannabis products to Texas residents who are coping with chronic medical conditions. As one of the three medical cannabis licensees in the state of Texas, our company is also well-positioned to begin building a network of conveniently located dispensaries in key markets where authorized under the new law by the Texas Department of Public Safety."
The new law, which is now effective, contains the following three key provisions that, together, are expected to increase legal access to low-level THC medical cannabis products:
         
1. Expands the range of medical conditions for which licensed specialty physicians may recommend low-level THC cannabis products (containing up to 0.5 percent THC). In addition to intractable epilepsy, which was previously the sole eligible condition, the following additional chronic conditions now qualify for cannabis recommendation:
     All forms of epilepsy
     Terminal Cancer
     Amyotrophic Lateral Sclerosis (ALS)
     Incurable neurological disease
     Parkinson's Disease
     Multiple Sclerosis
     Autism
     Seizure disorders
2. Enables a patient to gain access to medical cannabis products based on the recommendation of a single licensed specialty physician, versus the previous requirement that a patient obtain recommendations from at least two licensed physicians.
3.  Authorizes the Texas Department of Public Safety to oversee approval, regulation and administration of cannabis dispensaries to be constructed and operated by the state's three medical cannabis licensees, which include Cansortium.
Cansortium currently provides home-delivery services across Texas from a 4,000 square-foot cultivation facility and adjacent 650 square-foot processing facility in Schulenburg, Texas, with the ability to expand the cultivation facility up to an additional 200,000 square-feet to meet incremental demand. 
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411

  

Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories



#CryptoCorner: Facebook (NASDAQ: $FB) Releases White Paper for ‘Libra’, FB Subsidiary Calibra Announced, Ripple Partners with MoneyGram (NASDAQ: $MGI)

#CryptoCorner: Facebook (NASDAQ: $FB) Releases White Paper for ‘Libra’, FB Subsidiary Calibra Announced, Ripple Partners with MoneyGram (NASDAQ: $MGI)



Point Roberts WA, Delta BC, June 18, 2019 -  Investorideas.com, a leader in crypto and blockchain investing news, in partnership with Fit Pay, Inc.’s  (subsidiary of NXT-ID (NASDAQ: NXTD) crypto payment tech, Flip and  the Genesis Exchange and Wallet  App bring you today’s edition of the Crypto Corner podcast and commentary on what’s driving the cryptocurrency market .

Listen to today’s Crypto Corner Podcast:  


Subscribe to Podcast RSS feed:
https://www.investorideas.com/rss/feeds/Podcasts-Crypto.xml

June 18 Crypto Corner

Stocks discussed: (Nasdaq:FB) (Nasdaq:MGI)

Facebook (NasdaqGS:FB) today released the white paper for its global cryptocurrency Libra. The paper reads:

This document outlines our plans for a new decentralized blockchain, a low-volatility cryptocurrency, and a smart contract platform that together aim to create a new opportunity for responsible financial services innovation.

Built on the open source software-based Libra Blockchain, the Libra token is “fully backed by a reserve of real assets”. The digital currency is governed by an independent not-for-profit membership organization called Libra Association based in Geneva, Switzerland. The white paper outlines the goal of Libra, which is to make a stable and easy-to-use currency available to as many people around the world as possible:

Essential to the spirit of Libra, in both its permissioned and permissionless state, the Libra Blockchain will be open to everyone: any consumer, developer, or business can use the Libra network, build products on top of it, and add value through their services. Open access ensures low barriers to entry and innovation and encourages healthy competition that benefits consumers. This is foundational to the goal of building more inclusive financial options for the world.

Announced in tandem with Libra today was Facebook subsidiary Calibra, which will produce a digital wallet for Libra. The wallet is expected to launch in 2020 and will be available in Messenger, WhatsApp and as a standalone app. An excerpt from the announcement reads:

From the beginning, Calibra will let you send Libra to almost anyone with a smartphone, as easily and instantly as you might send a text message and at low to no cost. And, in time, we hope to offer additional services for people and businesses, like paying bills with the push of a button, buying a cup of coffee with the scan of a code or riding your local public transit without needing to carry cash or a metro pass.

Ripple has announced a strategic partnership with money transfer firm MoneyGram (NasdaqGS:MGI). The partnership will see Ripple become MoneyGram’s “partner for cross-border payment and foreign exchange settlement using digital assets”. Brad Garlinghouse, CEO of Ripple, explained:

“This strategic partnership will enable MoneyGram to greatly improve its operations and enable millions of people around the world to benefit from its improved efficiency. This is a huge milestone in helping to transform cross-border payments and I look forward to a long-term, very strategic partnership between our companies.”

The Korea Herald reports that five South Korean crypto exchanges have changed their terms of service so as to be liable for “cyberattacks or system malfunctions, even if operators are not willfully or grossly negligent”. This follows the five exchanges, which include Bithumb, receiving a corrective recommendation from the Fair Trade Commission last year.


Sam Mowers, Investorideas

Read other editions of the  Crypto Corner

Get the Crypto Corner News by email Get Crypto Corner News


Crypto Corner Sponsors:


Flip™ is the creation of Fit Pay, Inc., a leading provider of cutting edge payment technology and a subsidiary of NXT-ID (NASDAQ: NXTD). By leveraging the FitPay Payment Platform™, Flip enables cryptocurrency holders to seamlessly exchange their cryptocurrency for US dollars and store that value on a contactless payment device that can be used to make purchases at millions of retail locations.  https://www.fliptopay.com/




Genesis Exchange and Wallet App by Genesis Blockchain Technologies ( GBT)
@GenesisBlockch  , @GbtTechnologies
GBT is a powerful cryptocurrency centralized / decentralized exchange which will include a broad range of services and benefits from cryptocurrency and blockchain markets development, while avoiding complications and risks arising from crytocurrency ownership, transfer, and exchange.You can Download the Genesis Exchange and Wallet App at Google Play and on the Apple App Store. Learn more at  http://www.mygenesis.io




More info on the sector:
Investor Ideas is positioning as a  leader in blockchain and crypto content with its Bitcoin and Blockchain portals Bitcoinandblockchainstocks.comCryptocurrencyinvestorideas.com and Blockchaininvestorideas.com

For investors following the sector Investor Ideas has a comprehensive Bitcoin, Blockchain and Digital Currency Stocks Directory

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: this newsletter and podcast is sponsored content by featured companies NXt-ID (NASDAQ: NXTD) on behalf of Flip and GBT Technologies . More info: http://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Cryptocurrency Disclaimer
Investorideas.com news content is not meant to be a solicitation to buy or sell cryptocurrencies and Investorideas.com does not directly sell cryptocurrencies; but acts as a news and research resource for interested investors following the blockchain sector.

Copyright and ownership: Crypto Corner is an Investorideas.com content brand

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas

Contact Investorideas.com
800-665-0411




Get more Bitcoin and Blockchain Investor ideas  – news, articles, podcasts and stock directories 

Breaking #Hemp News from Tetra Bio-Pharma (TSXV: $TBP.V) (OTCQB: $TBPMF) - New Hemp Energy Drink to be offered to consumers in #cannabis accessory stores, vapes stores, and kiosks in Canada and the US

Breaking #Hemp News from Tetra Bio-Pharma (TSXV: $TBP.V) (OTCQB: $TBPMF) - New Hemp Energy Drink to be offered to consumers in #cannabis accessory stores, vapes stores, and kiosks in Canada and the US



OTTAWA, June 18, 2019—(Investorideas.com Newswire) Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX V: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) (“Spyder”) to distribute the three flavors of its Hemp Energy Drink in cannabis accessory stores and vapes stores in Canada and the US.

The drink is expected to be available to consumers in Spyder’s retail stores located in Scarborough, Woodbridge, Burlington, and shortly at the Niagara Falls and Pickering locations, which are expected to be opened early this summer. A launch event will be held during the Canada Day long weekend at the Niagara Falls location situated at 6474 Lundys Lane.





Tetra Bio-Pharma Hemp energy drinks

“We are very excited to be adding the Hemp Energy Drink to our portfolio of premium brands that will be available to our growing clientele,” stated Daniel Pelchovitz, CEO and President of Spyder. “This new offering will please our customers who are always seeking unique and distinctive quality products in this emerging industry.”

“This exclusive agreement allows us to take another step in implementing our distribution strategy and achieving our goal of making our Hemp Energy Drink accessible to all consumers “ said Richard Giguère, CEO of Tetra Natural Health “Consumers appreciate the qualities of the Hemp Energy Drink (HED) including the fact that it contains more natural ingredients than other energy drinks, and is the first energy drink made with hemp available in the country” adds Derek Theriault, National Sales Director of Tetra Natural Health.

About Tetra Natural Health:
Tetra Natural Health Inc. is a subsidiary of Tetra Bio-Pharma Inc. that focuses on identification, development and marketing of hemp or cannabis-based natural health products, or cannabinoids-based products authorized for sale by Health Canada. For more information, visit: www.tetranaturalhealth.com

About Spyder Cannabis Inc.
Founded in 2014 Spyder is an established chain of three high-end vape stores in Ontario, with stores located in Woodbridge, Scarborough and Burlington. The Spyder brand is defined by its high-quality proprietary line of e-juice, liquids and exclusive retail deals, dispensed in uniquely designed stores creating the optimal customer experience. Spyder is building off this leading retail, distribution and branding eCig and vapes company and is pursuing expansion into the legal cannabis market. Spyder has developed a scalable retail model with an aggressive expansion plan to create a significant retail footprint with targeted and disciplined retail distribution strategy focusing on Canadian locations in high traffic peripheral areas.

About Tetra Bio-Pharma:
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved and FDA reviewed clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Tetra Bio-Pharma has subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of its mission, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies. For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research and development strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.


More information at: www.tetrabiopharma.com

For more information, please contact:
Tetra Natural Health
Richard Giguère, CEO
Tel.: (348) 899-7575 ext. 210

Spyder Cannabis Inc.
Dan Pelchovitz, President and CEO
Tel: (905) 265-8273

For TBP investors information, please contact:
(438) 504-5784

Media Contacts - Tetra Natural Health
Daniel Granger
ACJ Communication
W. 514 840-7990
M. 514 232-1556
Charlotte Blanche
W. 514 840-1235, ext. 7772
M. 514 914-0593

Investorideas.com  publishing disclaimer:
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. This Tetra Bio-Pharma release is a paid for news release on Investorideas.com by( $750) learn  more about our 2 day news service https://www.investorideas.com/News-Upload/.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Cannabis disclaimer
Investor Ideas does not condone the use of cannabis except where permissible




Get more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories